$4500 | Single User
$6300 | Site License
$9000 | Enterprise License

Transplantation Diagnostics Global Market - Forecast to 2022
[Report Updated: 25-08-2016]

Published by IQ4I: 25 Aug 2016 | 111567 | In Stock
Related Topics: Abbott , Roche , Transplantation

Introduction

Transplantation is a surgical procedure of transferring organ, tissue or cell taken from one part of the body and grafted into another area of the same individual or another individual of same species or different species. The solid organ, tissue and stem cell transplantation field has evolved from a clinical experiment to routine and reliable practice, which has proven to be clinically effective, life-saving and cost-effective. The transplantation diagnostics market is segmented based on the technology, product type, applications, end users and geography. By technology the market is divided into molecular and non-molecular methods. By application, the transplantation diagnostics market is divided into diagnostic and research segments. By product the transplantation diagnostics market is divided into instruments, consumables, software and services, assays and kits. By end users the transplantation market is segmented into hospital and transplant centres, Research laboratories and academic institutes. Geographical wise, the transplantation market is segmented into North America, Europe, Asia- Pacific and rest of the world.

Among the transplantation diagnostics by technology, the non-molecular method is dominating the market by occupying a largest share and the molecular method is expected to grow at a highest CAGR from 2015 to 2022. The transplantation diagnostics market by product type is segmented into three major divisions such as instruments, consumables and software & services. Among these, consumables accounts for largest share and is growing at a strong CAGR from 2015 to 2022. By applications, is segmented into two major divisions such as diagnostic and research. Among these, diagnostic accounts for largest share as well as fastest growing segment. The end-users market of transplantation diagnostics market is segmented into three major divisions, hospital & transplant centres, diagnostic laboratories and research laboratories & academic institutions. Among these, hospital and transplant centres accounts for largest share and growing at a strong CAGR.

The transplantation diagnostics market is expected to grow at a high double digit CAGR to reach ,059.2 million by 2022. The factors driving the growth of this market are high incidence of organ and tissue transplantation procedures across the world, increasing geriatric population, coupled with an increasing population base for chronic disease, increasing healthcare awareness are likely to propel the market. In addition to this, increasing demand for early detection through non-invasive testing procedures like cell free DNA, increase in the number of deals by collaborations and acquisitions to open an array of opportunities for the market to flourish are some of the opportunities that are propelling the growth of the market. However, lack of trained health care professionals, ethical issues related to transplantation, high cost and non-affordability in developed as well as in low- and middle-income countries and unfavourable reimbursement policies are hampering the growth of the market. The threats for the transplantation diagnosticsmarket include the significant gap between the number of organs donated and the number of organs required.

The transplantation diagnostics market is a highly competitive market and all the existing players in this market are involved in developing new and advanced assays to maintain their market shares. The major players in the transplantation diagnostics market include Abbott Laboratories, Inc. (U.S.), Biofortuna Ltd (U.K.), Bio-Rad Laboratories, Inc. (U.S.), CareDx, Inc. (U.S.), Illumina, Inc. (U.S.), Immucor, Inc.(U.S.), Linkage biosciences (U.S.), Qiagen N.V. (Netherlands), Roche (Switzerland), Thermo Fisher Scientific, Inc. (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:

• North America

• Europe

• Asia-Pacific

• Rest of the World (RoW)

Table of Contents
for Transplantation Diagnostics Global Market - Forecast to 2022 [Report Updated: 25-08-2016]

  • 1 EXECUTIVE SUMMARY 21

    2 INTRODUCTION 31

    2.1 KEY TAKE AWAYS 31

    2.2 REPORT DESCRIPTION 31

    2.3 MARKETS COVERED 33

    2.4 STAKEHOLDERS 35

    2.5 RESEARCH METHODOLOGY 35

    2.5.1 MARKET SIZE ESTIMATION 36

    2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 39

    2.5.3 SECONDARY SOURCES 40

    2.5.4 PRIMARY SOURCES 41

    2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 41

    2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 42

    2.5.7 ASSUMPTIONS 42

    3 MARKET ANALYSIS 44

    3.1 INTRODUCTION 44

    3.2 MARKET SEGMENTATION 46

    3.3 FACTORS INFLUENCING MARKET 47

    3.3.1 DRIVERS AND OPPORTUNITIES 47

    3.3.1.1 Increase in the rate of solid organ, tissue and stem cell transplantation 47

    3.3.1.2 Increase in geriatric population coupled with chronic diseases 48

    3.3.1.3 Increase in research grants and funding 49

    3.3.1.4 Increasing demand for early detection through non-invasive testing

    procedures using cell-free DNA 50

    3.3.1.5 Growing awareness among people for organ donation and increase in

    healthcare expenditure 51

    3.3.1.6 Technological shift from serological assays to gene-based HLA profiling 52

    3.3.2 RESTRAINTS AND THREATS 52

    3.3.2.1 High device cost and non-affordability 52

    3.3.2.2 Limited medical reimbursements for organ donation and transplantation procedures 53

    3.3.2.3 Ethical issues related to transplantation 54

    3.3.2.4 Significant gap between the number of organs donated and the number of

    organs required annually is a major challenge limiting the growth of the

    global transplant diagnostic market 55

    3.4 REGULATORY AFFAIRS 56

    3.4.1 U.S. 56

    3.4.2 EUROPE 57

    3.4.3 INDIA 58

    3.4.4 CHINA 59

    3.4.5 JAPAN 59

    3.5 PORTERS FIVE FORCE ANALYSIS 60

    3.5.1 THREAT OF NEW ENTRANTS 61

    3.5.2 THREAT OF SUBSTITUTES 62

    3.5.3 COMPETITIVE RIVALRY 63

    3.5.4 BARGAINING POWER OF SUPPLIERS 63

    3.5.5 BARGAINING POWER OF BUYERS 64

    3.6 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 65

    3.7 RECENT AND UPCOMING PRODUCTS 67

    4 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY TECHNOLOGY 71

    4.1 INTRODUCTION 71

    4.2 MOLECULAR METHODS 74

    4.2.1 PCR BASED MOLECULAR METHODS 78

    4.2.1.1 SSP-PCR 82

    4.2.1.2 SSO-PCR 84

    4.2.1.3 Others 86

    4.2.1.3.1 SNP-PCR 86

    4.2.1.3.2 RFLP-PCR 87

    4.2.2 SEQUENCING BASED MOLECULAR METHODS 89

    4.2.2.1 NGS 92

    4.2.2.2 SANGER SEQUENCING 95

    4.3 NON-MOLECULAR METHODS 99

    4.3.1 SEROLOGICAL TESTS 102

    4.3.2 MIXED LYMPHOCYTE CULTURE ASSAY 105

    4.3.3 FLOW CYTOMETRY 106

    5 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY PRODUCT

    TYPE 109

    5.1 INTRODUCTION 109

    5.2 INSTRUMENTS 112

    5.3 CONSUMABLES 115

    5.4 SOFTWARE & SERVICES 120

    6 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY SCREENING

    METHODS 124

    6.1 INTRODUCTION 124

    6.2 PRE-TRANSPLANTATION SCREENING 126

    6.3 POST-TRANSPLANTATION SCREENING 128

    7 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY APPLICATION 131

    7.1 INTRODUCTION 131

    7.2 DIAGNOSTIC (MEDICAL) APPLICATION 134

    7.2.1 SOLID ORGAN TRANSPLANTATION DIAGNOSTICS 137

    7.2.1.1 Kidney Transplantation 141

    7.2.1.2 Heart Transplantation 143

    7.2.1.3 Liver Transplantation 145

    7.2.1.4 Other Transplantation 147

    7.2.2 STEM CELL TRANSPLANTATION 150

    7.2.3 TISSUE BASED TRANSPLANTATION 152

    7.3 RESEARCH APPLICATIONS 154

    8 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY END-USERS 157

    8.1 INTRODUCTION 157

    8.2 HOSPITALS AND TRANSPLANT CENTRES 159

    8.3 DIAGNOSTIC LABORATORIES 161

    8.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTIONS 163

    9 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET, BY REGION 165

    9.1 INTRODUCTION 165

    9.2 NORTH AMERICA 167

    9.2.1 U.S. 168

    9.2.2 CANADA 169

    9.3 EUROPE 182

    9.3.1 GERMANY 183

    9.3.2 SPAIN 183

    9.4 ASIA-PACIFIC 196

    9.4.1 CHINA 196

    9.4.2 INDIA 196

    9.4.3 AUSTRALIA 197

    9.5 REST OF THE WORLD 210

    10 COMPANY DEVELOPMENTS 223

    10.1 INTRODUCTION 223

    10.1.1 ACQUISTIONS & AGREEMENTS, COLLABORATIONS & PARTNERSHIPS

    AS A MAJOR GROWTH STRATEGY OF TRANSPLANTATION

    DIAGNOSTICS MARKET PLAYERS 223

    10.2 ACQUISITIONS 225

    10.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 227

    10.4 NEW PRODUCT LAUNCH 230

    10.5 APPROVALS 232

    10.6 OTHER DEVELOPMENTS 233

    11 COMPANY PROFILES 235

    11.1 ABBOTT LABORATORIES, INC. 235

    11.1.1 OVERVIEW 235

    11.1.2 FINANCIALS 236

    11.1.3 PRODUCT PORTFOLIO 239

    11.1.4 KEY DEVELOPMENTS 240

    11.1.5 BUSINESS STRATEGY 240

    11.1.6 SWOT ANALYSIS 241

    11.2 BIOFORTUNA LTD 242

    11.2.1 OVERVIEW 242

    11.2.2 FINANCIALS 242

    11.2.3 PRODUCT PORTFOLIO 242

    11.2.4 KEY DEVELOPMENTS 243

    11.2.5 BUSINESS STRATEGY 243

    11.2.6 SWOT ANALYSIS 244

    11.3 BIO-RAD LABORATORIES 245

    11.3.1 OVERVIEW 245

    11.3.2 FINANCIALS 246

    11.3.3 PRODUCT PORTFOLIO 248

    11.3.4 KEY DEVELOPMENTS 249

    11.3.5 BUSINESS STRATEGY 249

    11.3.6 SWOT ANALYSIS 250

    11.4 CAREDX, INC. 251

    11.4.1 OVERVIEW 251

    11.4.2 FINANCIALS 252

    11.4.3 PRODUCT PORTFOLIO 252

    11.4.4 KEY DEVELOPMENTS 253

    11.4.5 BUSINESS STRATEGY 254

    11.4.6 SWOT ANALYSIS 255

    11.5 ILLUMINA, INC. 256

    11.5.1 OVERVIEW 256

    11.5.2 FINANCIALS 257

    11.5.3 PRODUCT PORTFOLIO 259

    11.5.4 KEY DEVELOPMENTS 260

    11.5.5 BUSINESS STRATEGY 261

    11.5.6 SWOT ANALYSIS 262

    11.6 IMMUCOR, INC. 263

    11.6.1 OVERVIEW 263

    11.6.2 FINANCIALS 264

    11.6.3 PRODUCT PORTFOLIO 266

    11.6.4 KEY DEVELOPMENTS 267

    11.6.5 BUSINESS STRATEGY 269

    11.6.6 SWOT ANALYSIS 270

    11.7 LINKAGE BIOSCIENCES, INC. 271

    11.7.1 OVERVIEW 271

    11.7.2 FINANCIALS 271

    11.7.3 PRODUCT PORTFOLIO 271

    11.7.4 KEY DEVELOPMENTS 272

    11.7.5 BUSINESS STRATEGY 273

    11.7.6 SWOT ANALYSIS 274

    11.8 QIAGEN N.V. 275

    11.8.1 OVERVIEW 275

    11.8.2 FINANCIALS 276

    11.8.3 PRODUCT PORTFOLIO 278

    11.8.4 KEY DEVELOPMENTS 281

    11.8.5 BUSINESS STRATEGY 282

    11.8.6 SWOT ANALYSIS 283

    11.9 ROCHE HOLDINGS AG 284

    11.9.1 OVERVIEW 284

    11.9.2 FINANCIALS 285

    11.9.3 PRODUCT PORTFOLIO 289

    11.9.4 KEY DEVELOPMENTS 290

    11.9.5 BUSINESS STRATEGY 292

    11.9.6 SWOT ANALYSIS 293

    11.10 THERMO FISHER SCIENTIFIC, INC. 294

    11.10.1 OVERVIEW 294

    11.10.2 FINANCIALS 295

    11.10.3 PRODUCT PORTFOLIO 297

    11.10.4 KEY DEVELOPMENTS 300

    11.10.5 BUSINESS STRATEGY 301

    11.10.6 SWOT ANALYSIS 302

List Of Tables
in Transplantation Diagnostics Global Market - Forecast to 2022 [Report Updated: 25-08-2016]

LIST OF TABLES


TABLE 1 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 26

TABLE 2 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET REVENUE,

BY TECHNOLOGY, (2014-2022) ($MN) 27

TABLE 3 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET REVENUE,

BY PRODUCTS, (2014-2022) ($MN) 28

TABLE 4 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET REVENUE,

BY APPLICATION, (2014-2022) ($MN) 29

TABLE 5 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET REVENUE,

BY END-USERS, (2014-2022) ($MN) 30

TABLE 6 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET REVENUE,

BY TECHNOLOGY, (2014-2022) ($MN) 73

TABLE 7 MOLECULAR METHOD GLOBAL MARKET REVENUE, BY TYPE,

(2014-2022) ($MN) 76

TABLE 8 MOLECULAR METHOD GLOBAL MARKET REVENUE, BY REGION,

(2014-2022) ($MN) 77

TABLE 9 PCR BASED MOLECULAR METHOD GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 80

TABLE 10 PCR BASED MOLECULAR METHOD GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 81

TABLE 11 SSP-PCR BASED MOLECULAR METHOD GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 83

TABLE 12 SSO-PCR BASED MOLECULAR METHOD GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 85

TABLE 13 OTHERS BASED MOLECULAR METHOD GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 88

TABLE 14 SEQUENCING BASED MOLECULAR METHOD GLOBAL MARKET REVENUE,

BY TYPE, (2014-2022) ($MN) 91

TABLE 15 SEQUENCING BASED MOLECULAR METHOD GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 92

TABLE 16 NGS BASED MOLECUAR METHOD GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 95

TABLE 17 SANGER BASED MOLECULAR METHOD GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 98

TABLE 18 NON-MOLECULAR METHODS GLOBAL MARKET REVENUE,

BY TYPE, (2014-2022) ($MN) 100

TABLE 19 NON-MOLECULAR METHODS GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 101

TABLE 20 SEROLOGICAL TESTS GLOBAL MARKET REVENUE, BY REGION,

(2014-2022) ($MN) 104

TABLE 21 MIXED LYMPHOCYTE CULTURE ASSAY GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 106

TABLE 22 FLOW CYTOMETRY BASED NON-MOLECULAR METHOD GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 108

TABLE 23 TRANSPLANTATION DIAGNOSTICS GLOBALMARKET,

BY PRODUCTS, (2014-2022) ($MN) 111

TABLE 24 INSTRUMENTS GLOBAL MARKET, BY REGION, (2014-2022) ($MN) 114

TABLE 25 CONSUMABLES GLOBAL MARKET, BY REGION, (2014-2022) ($MN) 120

TABLE 26 SOFTWARE & SERVICES GLOBAL MARKET, BY REGION, (2014-2022) ($MN) 123

TABLE 27 TRANSPLANT DIAGNOSTICS GLOBAL MARKET REVENUE,

BY SCREENING METHODS, (2014-2022) ($MN) 126

TABLE 28 PRE-TRANSPLANTATION SCREENING GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 128

TABLE 29 POST-TRANSPLANTATION SCREENING GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 130

TABLE 30 TRANSPLANT DIAGNOSTIC GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN) 133

TABLE 31 DIAGNOSTICS (MEDICAL) APPLICATION GLOBAL MARKET REVENUE,

BY TYPE (2014-2022) ($MN) 136

TABLE 32 DIAGNOSTICS (MEDICAL) APPLICATION GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 137

TABLE 33 SOLID ORGAN TRANSPLANTATION APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 140

TABLE 34 SOLID ORGAN TRANSPLANTATION APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 141

TABLE 35 KIDNEY TRANSPLANTATION APPLICATION GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 143

TABLE 36 HEART TRANSPLANTATION APPLICATION GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 145

TABLE 37 LIVER TRANSPLANTATION APPLICATION GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 147

TABLE 38 OTHER TRANSPLANTATION APPLICATION GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 150

TABLE 39 STEM CELL TRANSPLANTATION APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 152

TABLE 40 TISSUE BASED TRANSPLANTATION APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 154

TABLE 41 RESEARCH APPLICATION GLOBAL MARKET REVENUE, BY REGION,

(2014-2022) ($MN) 156

TABLE 42 TRANSPLANT DIAGNOSTICS GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN) 159

TABLE 43 HOSPITALS AND TRANSPLANT CENTRES GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 161

TABLE 44 DIAGNOSTIC LABORATRIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 163

TABLE 45 RESEARCH LABORATORIES AND ACADEMIC INSTITUTIONS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 164

TABLE 46 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN) 167

TABLE 47 NORTH AMERICAN TRANSPLANTATION DIAGNOSTICS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 171

TABLE 48 NORTH AMERICAN MOLECULAR METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 172

TABLE 49 NORTH AMERICAN PCR BASED MOLECULAR METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 173

TABLE 50 NORTH AMERICAN SEQUENCING BASED MOLECULAR METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 174

TABLE 51 NORTH AMERICAN NON-MOLECULAR METHODS MARKET REVENUE,

BY TYPE, (2014-2022) ($MN) 175

TABLE 52 NORTH AMERICAN TRANSPLANTATION DIAGNOSTICS MARKET REVENUE,

BY PRODUCTS, (2014-2022) ($MN) 176

TABLE 53 NORTH AMERICAN TRANSPLANTATION DIAGNOSTICS MARKET

REVENUE, BY SCREENING METHODS, (2014-2022) ($MN) 177

TABLE 54 NORTH AMERICAN TRANSPLANTATION DIAGNOSTICS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN) 178

TABLE 55 NORTH AMERICAN DIAGNOSTIC APPLICATION MARKET REVENUE,

BY TYPE, (2014-2022) ($MN) 179

TABLE 56 NORTH AMERICAN SOLID ORGAN TRANSPLANTATION APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 180

TABLE 57 NORTH AMERICAN TRANSPLANT DIAGNOSTICS MARKET REVENUE,

BY END-USERS, (2014-2022) ($MN) 181

TABLE 58 EUROPEAN TRANSPLANTATION DIAGNOSTICS MARKET REVENUE,

BY TECHNOLOGY, (2014-2022) ($MN) 185

TABLE 59 EUROPEAN MOLECULAR METHOD MARKET REVENUE, BY TYPE,

(2014-2022) ($MN) 186

TABLE 60 EUROPEAN PCR BASED MOLECULAR METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 187

TABLE 61 EUROPEAN SEQUENCING BASED MOLECULAR METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 188

TABLE 62 EUROPEAN NON-MOLECULAR METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 189

TABLE 63 EUROPEAN TRANSPLANTATION DIAGNOSTICS MARKET REVENUE,

BY SCREENING METHODS, (2014-2022) ($MN) 190

TABLE 64 EUROPEAN TRANSPLANTATION DIAGNOSTICS MARKET REVENUE,

BY PRODUCTS, (2014-2022) ($MN) 191

TABLE 65 EUROPEAN TRANSPLANTATION DIAGNOSTICS MARKET REVENUE,

BY APPLICATION, (2014-2022) ($MN) 192

TABLE 66 EUROPEAN DIAGNOSTIC APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 193

TABLE 67 EUROPEAN SOLID ORGAN TRANSPLANTATION APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 194

TABLE 68 EUROPEAN TRANSPLANT DIAGNOSTICS MARKET REVENUE, BY END-USERS, (2014-2022) ($MN) 195

TABLE 69 ASIA-PACIFIC TRANSPLANTATION DIAGNOSTICS MARKET REVENUE,

BY TECHNOLOGY, (2014-2022) ($MN) 199

TABLE 70 ASIA-PACIFIC MOLECULAR METHOD MARKET REVENUE, BY TYPE,

(2014-2022) ($MN) 200

TABLE 71 ASIA-PACIFIC PCR BASED MOLECULAR METHODS MARKET REVENUE,

BY TYPE, (2014-2022) ($MN) 201

TABLE 72 ASIA-PACIFIC SEQUENCING BASED MOLECULAR METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 202

TABLE 73 ASIA-PACIFIC NON-MOLECULAR METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 203

TABLE 74 ASIA-PACIFIC TRANSPLANTATION DIAGNOSTICS MARKET REVENUE,

BY SCREENING METHODS, (2014-2022) ($MN) 204

TABLE 75 ASIA-PACIFIC TRANSPLANTATION DIAGNOSTICS MARKET REVENUE,

BY PRODUCTS, (2014-2022) ($MN) 205

TABLE 76 ASIA-PACIFIC TRANSPLANTATION DIAGNOSTICS MARKET REVENUE,

BY APPLICATION, (2014-2022) ($MN) 206

TABLE 77 ASIA-PACIFIC DIAGNOSTIC APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 207

TABLE 78 ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 208

TABLE 79 ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET REVENUE,

BY END-USERS, (2014-2022) ($MN) 209

TABLE 80 REST OF THE WORLD TRANSPLANTATION DIAGNOSTICS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN) 212

TABLE 81 REST OF THE WORLD TRANSPLANTATION DIAGNOSTICS MOLECULAR METHOD MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 213

TABLE 82 REST OF THE WORLD PCR BASED MOLECULAR METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 214

TABLE 83 REST OF THE WORLD SEQUENCING BASED MOLECULAR METHODS MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 215

TABLE 84 REST OF THE WORLD NON-MOLECULAR METHODS MARKET REVENUE,

BY TYPE, (2014-2022) ($MN) 216

TABLE 85 REST OF THE WORLD TRANSPLANTATION DIAGNOSTICS MARKET REVENUE, BY SCREENING METHODS, (2014-2022) ($MN) 217

TABLE 86 REST OF THE WORLD TRANSPLANTATION DIAGNOSTICS MARKET REVENUE, BY PRODUCTS, (2014-2022) ($MN) 218

TABLE 87 REST OF THE WORLD TRANSPLANTATION DIAGNOSTICS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN) 219

TABLE 88 REST OF THE WORLD DIAGNOSTIC APPLICATION MARKET REVENUE,

BY TYPE, (2014-2022) ($MN) 220

TABLE 89 REST OF THE WORLD SOLID ORGAN TRANSPLANTATION APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN) 221

TABLE 90 REST OF THE WORLD TRANSPLANT DIAGNOSTICS MARKET REVENUE,

BY END-USERS, (2014-2022) ($MN) 222

TABLE 91 ACQUISITIONS (2014-2016) 225

TABLE 92 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2014-2016) 228

TABLE 93 NEW PRODUCT LAUNCHES (2014-2016) 230

TABLE 94 APPROVALS, (2014-2016) 232

TABLE 95 OTHER DEVELOPMENTS (2014-2016) 233

TABLE 96 ABBOTT LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 236

TABLE 97 ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENTS,

(2013-2015) ($MN) 237

TABLE 98 ABBOTT LABORATORIES, INC.: TOTAL REVENUE, BY GEOGRAPHY,

(2013-2015) ($MN) 238

TABLE 99 BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES,

(2013-2015) ($MN) 246

TABLE 100 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS,

(2013-2015) ($MN) 247

TABLE 101 BIO-RAD LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY,

(2013-2015) ($MN) 248

TABLE 102 CAREDX, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 252

TABLE 103 ILLUMINA, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 257

TABLE 104 ILLUMINA, INC.: TOTAL REVENUE BY SEGMENTS, (2013-2015) ($MN) 258

TABLE 105 ILLUMINA, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN) 259

TABLE 106 IMMUCOR, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 264

TABLE 107 IMMUCOR, INC.: TOTAL REVENUE BY SEGMENTS, (2013-2015) ($MN) 265

TABLE 108 IMMUCOR, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN) 266

TABLE 109 QIAGEN N.V.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 276

TABLE 110 QIAGEN N.V.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN) 277

TABLE 111 QIAGEN N.V.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN) 277

TABLE 112 ROCHE HOLDINGS AG: TOTAL REVENUE AND R&D EXPENSES,

(2013-2015) ($MN) 285

TABLE 113 ROCHE HOLDINGS AG:TOTAL REVENUE BY SEGMENTS, (2013-2015) ($MN) 286

TABLE 114 ROCHE HOLDINGS AG: DIAGNOSTICS REVENUE BY TYPES,

(2013-2015) ($MN) 287

TABLE 115 ROCHE HOLDINGS AG: TOTAL REVENUE, BY GEOGRAPHY,

(2013-2015) ($MN) 288

TABLE 116 THERMOFISHER SCIENTIFIC, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN) 295

TABLE 117 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN) 296

TABLE 118 THERMO FISHER SCIENTIFIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN) 297

List Of Figures, Charts and Diagrams
in Transplantation Diagnostics Global Market - Forecast to 2022 [Report Updated: 25-08-2016]

LIST OF FIGURES



FIGURE 1 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET REVENUE,

BY REGION (2014-2022) ($MN) 25

FIGURE 2 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET: RESEARCH METHODOLOGY 36

FIGURE 3 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 37

FIGURE 4 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET: FORECASTING MODEL 38

FIGURE 5 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION 39

FIGURE 6 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET: MARKET SEGMENTATION 46

FIGURE 7 MARKET DYNAMICS 47

FIGURE 8 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET: PORTER’S ANALYSIS 61

FIGURE 9 TRANSPLANTATION DIAGNOSTICS MARKET SHARE ANALYSIS, 65

BY KEY PLAYERS, 2015 (%) 65

FIGURE 10 TRANSPLANT DIAGNOSTICS GLOBAL MARKET REVENUE,

BY TECHNOLOGY (2015 V’S 2022) ($MN) 72

FIGURE 11 TRANSPLANT DIAGNOSTICS GLOBAL MARKET REVENUE,

BY MOLECUAR METHODS, (2015 V’S 2022) ($MN) 75

FIGURE 12 PCR BASED MOLECULAR METHOD GLOBAL MARKET REVENUE,

BY TYPE, (2015 V’S 2022) ($MN) 79

FIGURE 13 SEQUENCING BASED MOLECUAR METHOD GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN) 90

FIGURE 14 NON-MOLECUAR METHODS GLOBAL MARKET REVENUE, BY TYPE,

(2015 V’S 2022) ($MN) 99

FIGURE 15 TRANSPLANTATION DIAGNOSTICS GLOBAL MARKET REVENUE,

BY PRODUCTS, (2015 V’S 2022) ($MN) 110

FIGURE 16 TRANSPLANT DIAGNOSTICS GLOBAL MARKET REVENUE,

BY SCREENING METHODS, (2015 V’S 2022) ($MN) 125

FIGURE 17 TRANSPLANT DIAGNOSTICS GLOBAL MARKET REVENUE,

BY APPLICATION, (2015 V’S 2022) ($MN) 132

FIGURE 18 DIAGNOSTIC (MEDICAL) APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN) 135

FIGURE 19 SOLID ORGAN TRANSPLANTATION GLOBAL MARKET REVENUE,

BY TYPE, (2015 V’S 2022) ($MN) 139

FIGURE 20 TRANSPLANT DIAGNOSTICS GLOBAL MARKET REVENUE,

BY END USERS (2015 V’S 2022) ($MN) 158

FIGURE 21 TRANSPLANTATION DIANOSTICS GLOBAL MARKET REVENUE,

BY REGION, (2014-2022) ($MN) 166

FIGURE 22 NORTH AMERICAN TRANSPLANTATION DIAGNOSTICS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS, APPLICATION & END-USERS, (2015 V’S 2022) ($MN) 170

FIGURE 23 EUROPEAN TRANSPLANTATION DIAGNOSTICS MARKET REVENUE,

BY TECHNOLOGY, PRODUCTS, APPLICATION & END-USERS,

(2015 V’S 2022) ($MN) 184

FIGURE 24 ASIA-PACIFIC TRANSPLANTATION DIAGNOSTICS MARKET REVENUE,

BY TECHNOLOGY, PRODUCTS, APPLICATION & END-USERS

(2015 V’S 2022) ($MN) 198

FIGURE 25 REST OF THE WORLD TRANSPLANTATION DIAGNOSTICS MARKET REVENUE, BY TECHNOLOGY, PRODUCTS, APPLICATION & END-USERS, (2015 V’S 2022) ($MN) 211

FIGURE 26 KEY GROWTH STRATEGIES, (2014-2016) 224

FIGURE 27 SWOT: ABBOTT LABORATORIES, INC. 241

FIGURE 28 SWOT: BIOFORTUNA LTD 244

FIGURE 29 SWOT: BIO-RAD LABORATORIES 250

FIGURE 30 SWOT: CAREDX, INC. 255

FIGURE 31 SWOT: ILLUMINA, INC. 262

FIGURE 32 SWOT: IMMUCOR, INC. 270

FIGURE 33 SWOT: LINKAGE BIOSCIENCES 274

FIGURE 34 SWOT: QIAGEN N.V. 283

FIGURE 35 SWOT: ROCHE HOLDINGS AG 293

FIGURE 36 SWOT: THERMO FISHER SCIENTIFIC 30

Additional Details

Publisher

IQ4I

Publisher Information

IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.



We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.

Reference

111567 | Transplantation Diagnostics Global Market Report 25082016

Number of Pages

303

Report Format

PDF

IQ4I Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Transplantation Partnering 2010 to 2017
The Global Transplantation Partnering Terms and Agreements since 2010 report provides understanding ...
01 Feb 2017 by Current Partnering USD $1,495 More Info
Cartilage Repair/ Cartilage Regeneration Market by Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), Region - Forecast to 2021
The global cartilage repair/ cartilage regeneration market is projected to reach USD 779.8 million b...
05 Dec 2016 by MarketsandMarkets USD $5,650 More Info
Global Transplantation Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Transplantation Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Stem Cell Transplantation Global Clinical Trials Review, H2, 2016
Stem Cell Transplantation Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial ...
30 Sep 2016 by Global Data USD $2,500 More Info
Stem Cell Transplantation Global Clinical Trials Review, H2, 2016
Stem Cell Transplantation Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial ...
30 Sep 2016 by Global Data USD $2,500 More Info
Transplantation Diagnostics Global Market - Forecast to 2022
Transplantation is a surgical procedure of transferring organ, tissue or cell taken from one part of...
25 Aug 2016 by IQ4I USD $4,500 More Info
Transplantation Diagnostics Global Market - Forecast to 2022
Transplantation is a surgical procedure of transferring organ, tissue or cell taken from one part of...
25 Aug 2016 by IQ4I USD $4,500 More Info
Transplantation Diagnostics Global Market - Forecast to 2022
Transplantation is a surgical procedure of transferring organ, tissue or cell taken from one part of...
25 Aug 2016 by IQ4I USD $4,500 More Info
Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015
Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015SummaryGlobalData's c...
30 Dec 2015 by Global Data USD $2,500 More Info

This report is published by IQ4I

IQ4I is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.

We are a team of highly qualified market researchers and consultants, committed to help clients make strategic decisions by providing relevant and firmly reliable data support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports and Business Development & licensing services and provide support in hiring with best talents.

Download Free Report Summary PDF

Transplantation Diagnostics Global Market - Forecast to 2022 [Report Updated: 25-08-2016] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...